CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients
Sara Pelucchi,
Raffaella Mariani,
Stefano Calza,
Anna Ludovica Fracanzani,
Giulia Litta Modignani,
Francesca Bertola,
Fabiana Busti,
Paola Trombini,
Mirella Fraquelli,
Gian Luca Forni,
Domenico Girelli,
Silvia Fargion,
Claudia Specchia,
Alberto Piperno
Affiliations
Sara Pelucchi
Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy
Raffaella Mariani
Center for Diagnosis and Treatment of Hemochromatosis, S. Gerardo Hospital, Monza, Italy
Stefano Calza
Department of Biomedical Sciences and Biotechnologies, University of Brescia, Brescia, Italy;Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Anna Ludovica Fracanzani
Department of Medicine, IRCCS, Ospedale Maggiore Policlinico, University of Milano, Milano, Italy
Giulia Litta Modignani
Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy
Francesca Bertola
Consortium for Human Molecular Genetics, Monza, Italy
Fabiana Busti
Department of Medicine Policlinico GB Rossi, University of Verona, Verona, Italy
Paola Trombini
Center for Diagnosis and Treatment of Hemochromatosis, S. Gerardo Hospital, Monza, Italy
Mirella Fraquelli
Second Division of Gastroenterology, IRCCS, Ospedale Maggiore Policlinico, University of Milano, Milano, Italy
Gian Luca Forni
Centre of Microcitemia and Congenital Anemias, Galliera Hospital, Genova, Italy
Domenico Girelli
Department of Medicine Policlinico GB Rossi, University of Verona, Verona, Italy
Silvia Fargion
Department of Medicine, IRCCS, Ospedale Maggiore Policlinico, University of Milano, Milano, Italy
Claudia Specchia
Department of Biomedical Sciences and Biotechnologies, University of Brescia, Brescia, Italy
Alberto Piperno
Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy;Center for Diagnosis and Treatment of Hemochromatosis, S. Gerardo Hospital, Monza, Italy;Consortium for Human Molecular Genetics, Monza, Italy
Background Most patients with hereditary hemochromatosis in the Caucasian population are homozygous for the p.C282Y mutation in the HFE gene. The penetrance and expression of hereditary hemochromatosis differ largely among cases of homozygous p.C282Y. Genetic factors might be involved in addition to environmental factors.Design and Methods: In the present study, we analyzed 50 candidate genes involved in iron metabolism and evaluated the association between 214 single nucleotide polymorphisms in these genes and three phenotypic outcomes of iron overload (serum ferritin, iron removed and transferrin saturation) in a large group of 296 p.C282Y homozygous Italians. Polymorphisms were tested for genetic association with each single outcome using linear regression models adjusted for age, sex and alcohol consumption.Results We found a series of 17 genetic variants located in different genes with possible additive effects on the studied outcomes. In order to evaluate whether the selected polymorphisms could provide a predictive signature for adverse phenotype, we re-evaluated data by dividing patients in two extreme phenotype classes based on the three phenotypic outcomes. We found that only a small improvement in prediction could be achieved by adding genetic information to clinical data. Among the selected polymorphisms, a significant association was observed between rs3806562, located in the 5'UTR of CYBRD1, and transferrin saturation. This variant belongs to the same haplotype block that contains the CYBRD1 polymorphism rs884409, found to be associated with serum ferritin in another population of p.C282Y homozygotes, and able to modulate promoter activity. A luciferase assay indicated that rs3806562 does not have a significant functional role, suggesting that it is a genetic marker linked to the putative genetic modifier rs884409.Conclusions While our results support the hypothesis that polymorphisms in genes regulating iron metabolism may modulate penetrance of HFE-hereditary hemochromatosis, with emphasis on CYBRD1, they strengthen the notion that none of these polymorphisms alone is a major modifier of the phenotype of hereditary hemochromatosis.